Literature DB >> 46255

Induction of tolerance to nucleic acid determinants by administration of a complex of nucleoside D-glutamic acid and D-lysine (D-GL).

Z Eshhar, B Benacerraf, D H Katz.   

Abstract

The administration of nucleosides coupled covalently to the copolymer of D-glutamic acid and D-lysine (D-GL) or to its stereoisomer, L-GL, induces a state of nucleoside (NUC)-specific tolerance in inbred SJL and BALB/c mice, irrespective of their immune status at the time of treatment. Such tolerance is characterized by the inability of treated animals to mount either primary or secondary, intact or adoptive, anti-NUC antibody responses following immunization with a highly immunogenic conjugate of NUC-Keyhole limpet hemocyanin. These observations have potential therapeutic importance in autoimmune processes involving anti-DNA antibody production.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 46255

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Oligonucleotide linked to human gammaglobulin specifically diminishes anti-DNA antibody formation in cultured lymphoid cells from patients with systemic lupus erythematosus.

Authors:  Y Borel; H Borel
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

2.  Immunological tolerance to allergenic protein determinants: a therapeutic approach for selective inhibition of IgE antibody production.

Authors:  F T Liu; D H Katz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

3.  Induction if immunological tolerance to the major antigenic determinant of penicillin: a therapeutic approach to penicillin allergy.

Authors:  N Chiorazzi; Z Eshhar; D H Katz
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

4.  In vitro nucleoside specific immune response by lymphocytes from systemic lupus erythematosus.

Authors:  C Morimoto; A D Steinberg; S F Schlossman; Y Borel
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

5.  Induction of a stable hapten-specific immunosuppression by a hapten conjugated to poly(N-vinylpyrrolidone) (PVP).

Authors:  B U Von Specht; L Milgrom; S Segal
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.